Divergent opioid-mediated suppression of inhibition between hippocampus and neocortex across species and development
Adam P. Caccavano,Anna Vlachos,Nadiya McLean,Sarah Kimmel,June Hoan Kim,Geoffrey Vargish,Vivek Mahadevan,Lauren Hewitt,Anthony M. Rossi,Ilona Spineux,Sherry Jingjing Wu,Elisabetta Furlanis,Min Dai,Brenda Leyva Garcia,Ramesh Chittajallu,Edra London,Xiaoqing Yuan,Steven Hunt,Daniel Abebe,Mark A. G. Eldridge,Alex C. Cummins,Brendan E. Hines,Anya Plotnikova,Arya Mohanty,Bruno B. Averbeck,Kareem Zaghloul,Jordane Dimidschstein,Gord Fishell,Kenneth A. Pelkey,Chris J. McBain
DOI: https://doi.org/10.1101/2024.01.20.576455
2024-11-02
Abstract:Opioid receptors within the CNS regulate pain sensation and mood and are key targets for drugs of abuse. Within the adult rodent hippocampus (HPC), μ-opioid receptor agonists suppress inhibitory parvalbumin-expressing interneurons (PV-INs), thus disinhibiting the circuit. However, it is uncertain if this disinhibitory motif is conserved in other cortical regions, species, or across development. We observed that PV-IN mediated inhibition is robustly suppressed by opioids in hippocampus proper but not neocortex in mice and nonhuman primates, with spontaneous inhibitory tone in resected human tissue also following a consistent dichotomy. This hippocampal disinhibitory motif was established in early development when PV-INs and opioids were found to regulate primordial network rhythmogenesis. Acute opioid-mediated modulation was partially occluded with morphine pretreatment, with implications for the effects of opioids on hippocampal network activity important for learning and memory. Together, these findings demonstrate that PV-INs exhibit a divergence in opioid sensitivity across brain regions that is remarkably conserved across evolution and highlights the underappreciated role of opioids acting through immature PV-INs in shaping hippocampal development.
Neuroscience